Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
The Journal of Allergy and Clinical Immunology|February 27, 2007
An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthmaThomas Charles, Dean Quinn, Mark Weatherall, et al.Journal of Orthopaedic Surgery (Hong Kong)|July 16, 2002
Polyethylene particles from a hip simulator cause (45)Ca release from cultured boneKate Y Wang, J Geoffrey Horne, Peter A Devane, et al.Clinical Orthopaedics and Related Research|March 28, 2012
Do joint registries report true rates of hip dislocation?Peter A Devane, Philip J Wraighte, David C G Ong, et al.The Journal of Arthroplasty|June 13, 2008
A double-blind, prospective, randomized controlled trial comparing highly cross-linked and conventional polyethylene in primary total hip arthroplastyGeorge T Calvert, Peter A Devane, Jan Fielden, et al.Respirology (Carlton, Vic.)|February 26, 2004
The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamolAlexandra Goldkorn, Patricia Diotto, Carl Burgess, et al.The Journal of Bone and Joint Surgery. American Volume|October 18, 2017
Highly Cross-Linked Polyethylene Reduces Wear and Revision Rates in Total Hip Arthroplasty: A 10-Year Double-Blinded Randomized Controlled TrialPeter A Devane, James Geoffrey Horne, Alexander Ashmore, et al.Journal of Orthopaedic Surgery (Hong Kong)|December 7, 2002
Chemical eluates from ultra-high molecular weight polyethylene and fibroblast proliferationKate Y Wang, J Geoffrey Horne, Peter A Devane, et al.Respirology (Carlton, Vic.)|February 22, 2016
Effect of smoking status on the efficacy of the SMART regimen in high risk asthmaJanine Pilcher, Mitesh Patel, Helen K Reddel, et al.The Lancet. Respiratory Medicine|December 11, 2013
Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trialMitesh Patel, Janine Pilcher, Alison Pritchard, et al.Diabetes, Obesity & Metabolism|June 3, 2017
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutideHertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, et al.Pageof 5